Quinn, J. A., Desjardins, A., Reardon, D., Vredenburgh, J., Rich, J., Gururangan, S., … Friedman, H. S. (2004). Phase II trial of temozolomide (Temodar) plus O6-benzylguanine (O6-BG) in the treatment of patients with Temodar-resistant malignant glioma. In NEURO-ONCOLOGY (Vol. 6, pp. 380–380). Toronto, CANADA: DUKE UNIV PRESS.

Quinn, J. A., A. Desjardins, D. Reardon, J. Vredenburgh, J. Rich, S. Gururangan, A. Friedman, et al. “Phase II trial of temozolomide (Temodar) plus O6-benzylguanine (O6-BG) in the treatment of patients with Temodar-resistant malignant glioma.” In NEURO-ONCOLOGY, 6:380–380. DUKE UNIV PRESS, 2004.

Quinn JA, Desjardins A, Reardon D, Vredenburgh J, Rich J, Gururangan S, et al. Phase II trial of temozolomide (Temodar) plus O6-benzylguanine (O6-BG) in the treatment of patients with Temodar-resistant malignant glioma. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 380–380.

Quinn, J. A., et al. “Phase II trial of temozolomide (Temodar) plus O6-benzylguanine (O6-BG) in the treatment of patients with Temodar-resistant malignant glioma.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 380–380.

Quinn JA, Desjardins A, Reardon D, Vredenburgh J, Rich J, Gururangan S, Friedman A, Sampson J, Provenzale J, McLendon R, Herndon J, Dolan ME, Badruddoja M, Walker A, Tourt-Uhlig S, Friedman HS. Phase II trial of temozolomide (Temodar) plus O6-benzylguanine (O6-BG) in the treatment of patients with Temodar-resistant malignant glioma. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 380–380.